MIR34A and neoplasm: (22) demonstrated, through scRNA-seq, an increase in specific macrophage subtypes, ultimately confirming that the knockdown of Mir34a in bone marrow cells could inhibit the polarization of tumor-associated macrophage M2, thereby delaying the progression of colon cancer.